Neurofibromatosis type 1: a multidisciplinary approach to care
Neurofibromatosis type 1 is a relatively common inherited disorder. Patients have a high
predisposition to develop both benign and malignant tumours. Although many …
predisposition to develop both benign and malignant tumours. Although many …
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
Summary Background Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder,
predisposing development of benign and malignant tumours. Given the oncogenic potential …
predisposing development of benign and malignant tumours. Given the oncogenic potential …
Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis
Background Meta-analyses were performed to examine the utility of ultrasonography,
computed tomography (CT), positron emission tomography (PET), and a combination of both …
computed tomography (CT), positron emission tomography (PET), and a combination of both …
Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version
T Nishida, S Hirota, A Yanagisawa, Y Sugino… - International journal of …, 2008 - Springer
Diagnostic and treatment strategies for gastrointestinal stromal tumors (GISTs) have evolved
greatly since the introduction of molecularly targeted therapies. Although several clinical …
greatly since the introduction of molecularly targeted therapies. Although several clinical …
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of …
Purpose Imatinib is the standard treatment of advanced GI stromal tumors (GISTs). It is not
known whether imatinib may be stopped in patients in whom disease is controlled. Methods …
known whether imatinib may be stopped in patients in whom disease is controlled. Methods …
Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study
Gastrointestinal stromal tumours (GIST) are identified by their specific morphology added
with immunohistochemical staining with anti-CD117, the phenotypic marker for GIST in the …
with immunohistochemical staining with anti-CD117, the phenotypic marker for GIST in the …
Combined surgical and molecular therapy: the gastrointestinal stromal tumor model
Objective: This review describes the pathologic and epidemiologic features of
gastrointestinal stromal tumor (GIST) as well as the contemporary management of this tumor …
gastrointestinal stromal tumor (GIST) as well as the contemporary management of this tumor …
[HTML][HTML] Preoperative diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration
AIM: To evaluate the role of endoscopic ultrasonography-guided fine needle aspiration
(EUS-FNA) in the preoperative diagnosis of gastrointestinal stromal tumor (GIST) …
(EUS-FNA) in the preoperative diagnosis of gastrointestinal stromal tumor (GIST) …
[HTML][HTML] Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor
DH Koo, MH Ryu, KM Kim, HK Yang… - … : official journal of …, 2016 - synapse.koreamed.org
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors
originating in the gastrointestinal tract. With the introduction of molecular-targeted therapy for …
originating in the gastrointestinal tract. With the introduction of molecular-targeted therapy for …
Nasopharyngeal carcinoma: the next challenges
Nasopharyngeal carcinoma (NPC) differs from other head and neck cancers in its aetiology,
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …
epidemiology and potential therapeutic options. Despite cure for the majority of the patients …